Bharath Yarlagadda is a Cardiology physician affiliated with University of New Mexico. OpenAlex indexes 39 publications with 403 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Msc Cardiology 1 University Of New Mexico
Albuquerque, NM 871311000
Telephone
505-272-9223Provider last certified this registry record 30 Oct 2024.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- LANTHEUS MEDICAL IMAGING, INC.Program year20251 payment
- GE HEALTHCAREProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.9%Beta blocker22.6%Carvedilol47%Metoprolol Succinate34%Metoprolol Tartrate19%Part D≥30 patientsLoop diuretic10.9%Furosemide61%Bumetanide39%Part D<11 patients+ 12 more classes in this area
Blood & clotting
10.4%Factor Xa inhibitor8.3%Eliquis100%Part D≥24 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
5.7%Potassium supplement5.7%Potassium Chloride100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- DEFYING THE ODDS: SUCCESSFUL MANAGEMENT OF SEVERE ICI-RELATED MYOCARDITIS
Journal of the American College of Cardiology
2025 - Disparities in access, utilization, and outcomes of percutaneous coronary intervention in Hispanics compared to non-Hispanic Whites in the United States: A comprehensive review
Cardiovascular revascularization medicine
2025 - Role of the Left Atrial Appendage in Systemic Homeostasis, Arrhythmogenesis, and Beyond
Cardiac Electrophysiology Clinics
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Mauricio Tohen, MD, DRPH, MBA
University of New Mexico
Howard Yonas, MD
University of New Mexico
Rhoshel Lenroot, MD
University of New Mexico
Mark Unruh, MD
University of New Mexico
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”